Accuray Company Description
Accuray's CyberKnife radiosurgery system zaps tumors with precisely aimed, high-dose radiation. The system, approved for use in the US, the EU, and several Asian countries, improves upon older radiosurgery systems that have limited mobility and are mostly used to treat brain tumors. Doctors can use CyberKnife to treat tumors anywhere in the body; the system tracks and adjusts for movement in real time, allowing for patient and tumor movement. Procedures with CyberKnife require no anesthesia and can be performed on an outpatient basis. Around 140 of the systems have been installed in hospitals around the world, more than 70 of them in the US.
View the Comprehensive Company Description for Accuray
The Company Description provides a historical perspective of Accuray's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Accuray's evolution in the marketplace.
